ACON, NSW’s leading LGBTQ+ community health organisation, says gender-affirming care should be guided by the best available evidence following the release of the National Health and Medical Research Council’s (NHMRC) advice on puberty suppressants.
The advice released today recognises that puberty suppressants can be an appropriate treatment option for some young people aged under 18 with gender incongruence and includes a conditional recommendation for their use.

ACON CEO Michael Woodhouse said the organisation would be reviewing the advice closely.
“Trans and gender-diverse people and clinicians need access to the best available evidence. We will be reviewing the interim advice to ensure that is what it provides.
“Once the evidence is clear, decisions about care should be made between clinicians and patients.”
Woodhouse said history has shown that medical treatment should be guided by evidence rather than moral concerns.
“Evidence-based healthcare delivers better health outcomes for our communities. From the earliest days of HIV through to reducing drug-related harm, we have made progress by following the evidence, even when it has conflicted with some people’s moral positions.
“We will continue to deliver services that follow the evidence and give trans and gender-diverse people access to information and knowledge so they can make decisions about their own healthcare.”
ACON said it will update TransHub, its online information portal, with information about the NHMRC advice, including expert analysis and guidance on how people can engage with the consultation process.
“We are also conscious that discussion of gender-affirming care can lead to public debate that many trans people will find hurtful or distressing. TransHub includes information on services that can offer support should you need it,” Woodhouse said.
ACON follows in the footsteps of Equality Australia, Transcend, AusPATH, LGBTIQ Health Australia, and headspace – who have all welcomed the announcement.





